Chinese- REPORT SUMMARY
- TABLE OF CONTENTS
-
Encorafenib market report explains the definition, types, applications, major countries, and major players of the Encorafenib market. The report mainly contains different types, applications, and regional historical data from 2017-2021 and forecast data from 2022-2028.
The report contains qualitative and quantitative analysis of the entire industry.
The influence of COVID-19 has been considered in the report. Coronavirus Impact is included in Chapter 2. In addition, Strategic Analytics to Boost Productivity and Profitability is included in Chapter 3.
By Player:
Array BioPharma
By Type:
50mg Capsules
75mg Capsules
By End-User:
Hospital
Clinic
Pharmacy
Other
By Region:
North America
-
United States
-
Canada
-
Mexico
Europe
-
Germany
-
UK
-
Spain
-
France
-
Italy
-
Denmark
-
Finland
-
Norway
-
Sweden
-
Poland
-
Russia
-
Turkey
Asia-Pacific
-
China
-
Japan
-
India
-
South Korea
-
Pakistan
-
Bangladesh
-
Indonesia
-
Thailand
-
Singapore
-
Malaysia
-
Philippines
-
Vietnam
-
Others
South America
-
Brazil
-
Colombia
-
Chile
-
Argentina
-
Venezuela
-
Peru
-
Puerto Rico
-
Ecuador
-
Others
GCC
-
Bahrain
-
Kuwait
-
Oman
-
Qatar
-
Saudi Arabia
-
United Arab Emirates
Africa
-
Nigeria
-
South Africa
-
Egypt
-
Algeriat
-
Others
Oceania
-
Australia
-
New Zealand
TABLE OF CONTENT
1. Global Encorafenib Executive Summary
-
1.1 Introduction
-
1.2 Market Panorama, 2022
2 Coronavirus Impact
-
2.1 Encorafenib Outlook to 2028- Original Forecasts
-
2.2 Encorafenib Outlook to 2028- COVID-19 Affected Forecasts
-
2.3 Impact on Industry
3 Strategic Analytics to Boost Productivity and Profitability
-
3.1 Potential Market Drivers and Opportunities
-
3.2 New Challenges and Strategies
-
3.3 Short Term and Long Term Encorafenib Market Trends
4 Key Inferences
5 Market Overview
-
5.1 Current Market Scenario
-
5.2 Porter's Five Forces Analysis
-
5.2.1 Bargaining Power of Suppliers
-
5.2.2 Bargaining Power of Consumers
-
5.2.3 Threat of New Entrants
-
5.2.4 Threat of Substitute Product and Services
-
5.2.5 Competitive Rivalry within the Industry
6 Global Encorafenib Market- Recent Developments
-
6.1 Encorafenib Market News and Developments
-
6.2 Encorafenib Market Deals Landscape
7 Encorafenib Raw Materials and Cost Structure Analysis
-
7.1 Encorafenib Key Raw Materials
-
7.2 Encorafenib Price Trend of Key Raw Materials
-
7.3 Encorafenib Key Suppliers of Raw Materials
-
7.4 Encorafenib Market Concentration Rate of Raw Materials
-
7.5 Encorafenib Cost Structure Analysis
-
7.5.1 Encorafenib Raw Materials Analysis
-
7.5.2 Encorafenib Labor Cost Analysis
-
7.5.3 Encorafenib Manufacturing Expenses Analysis
8 Global Encorafenib Import and Export Analysis (Top 10 Countries)
-
8.1 Global Encorafenib Import by Region (Top 10 Countries) (2017-2028)
-
8.2 Global Encorafenib Export by Region (Top 10 Countries) (2017-2028)
9 Global Encorafenib Market Outlook by Types and Applications to 2022
-
9.1 Global Encorafenib Consumption and Growth Rate by Type (2017-2022)
-
9.1.1 Global 50mg Capsules Consumption and Growth Rate (2017-2022)
-
9.1.2 Global 75mg Capsules Consumption and Growth Rate (2017-2022)
-
9.2 Global Encorafenib Consumption and Growth Rate by Application (2017-2022)
-
9.2.1 Global Hospital Consumption and Growth Rate (2017-2022)
-
9.2.2 Global Clinic Consumption and Growth Rate (2017-2022)
-
9.2.3 Global Pharmacy Consumption and Growth Rate (2017-2022)
-
9.2.4 Global Other Consumption and Growth Rate (2017-2022)
10 Region and Country-wise Encorafenib Market Analysis and Outlook till 2022
-
10.1 Global Encorafenib Consumption (2017-2022)
-
10.2 North America Consumption Analysis
-
10.2.1 United States Encorafenib Consumption (2017-2022)
-
10.2.2 Canada Encorafenib Consumption (2017-2022)
-
10.2.3 Mexico Encorafenib Consumption (2017-2022)
-
10.3 Europe Consumption Analysis
-
10.3.1 Germany Encorafenib Consumption (2017-2022)
-
10.3.2 UK Encorafenib Consumption (2017-2022)
-
10.3.3 Spain Encorafenib Consumption (2017-2022)
-
10.3.4 Belgium Encorafenib Consumption (2017-2022)
-
10.3.5 France Encorafenib Consumption (2017-2022)
-
10.3.6 Italy Encorafenib Consumption (2017-2022)
-
10.3.7 Denmark Encorafenib Consumption (2017-2022)
-
10.3.8 Finland Encorafenib Consumption (2017-2022)
-
10.3.9 Norway Encorafenib Consumption (2017-2022)
-
10.3.10 Sweden Encorafenib Consumption (2017-2022)
-
10.3.11 Poland Encorafenib Consumption (2017-2022)
-
10.3.12 Russia Encorafenib Consumption (2017-2022)
-
10.3.13 Turkey Encorafenib Consumption (2017-2022)
-
10.4 APAC Consumption Analysis
-
10.4.1 China Encorafenib Consumption (2017-2022)
-
10.4.2 Japan Encorafenib Consumption (2017-2022)
-
10.4.3 India Encorafenib Consumption (2017-2022)
-
10.4.4 South Korea Encorafenib Consumption (2017-2022)
-
10.4.5 Pakistan Encorafenib Consumption (2017-2022)
-
10.4.6 Bangladesh Encorafenib Consumption (2017-2022)
-
10.4.7 Indonesia Encorafenib Consumption (2017-2022)
-
10.4.8 Thailand Encorafenib Consumption (2017-2022)
-
10.4.9 Singapore Encorafenib Consumption (2017-2022)
-
10.4.10 Malaysia Encorafenib Consumption (2017-2022)
-
10.4.11 Philippines Encorafenib Consumption (2017-2022)
-
10.4.12 Vietnam Encorafenib Consumption (2017-2022)
-
10.5 South America Consumption Analysis
-
10.5.1 Brazil Encorafenib Consumption (2017-2022)
-
10.5.2 Colombia Encorafenib Consumption (2017-2022)
-
10.5.3 Chile Encorafenib Consumption (2017-2022)
-
10.5.4 Argentina Encorafenib Consumption (2017-2022)
-
10.5.5 Venezuela Encorafenib Consumption (2017-2022)
-
10.5.6 Peru Encorafenib Consumption (2017-2022)
-
10.5.7 Puerto Rico Encorafenib Consumption (2017-2022)
-
10.5.8 Ecuador Encorafenib Consumption (2017-2022)
-
10.6 GCC Consumption Analysis
-
10.6.1 Bahrain Encorafenib Consumption (2017-2022)
-
10.6.2 Kuwait Encorafenib Consumption (2017-2022)
-
10.6.3 Oman Encorafenib Consumption (2017-2022)
-
10.6.4 Qatar Encorafenib Consumption (2017-2022)
-
10.6.5 Saudi Arabia Encorafenib Consumption (2017-2022)
-
10.6.6 United Arab Emirates Encorafenib Consumption (2017-2022)
-
10.7 Africa Consumption Analysis
-
10.7.1 Nigeria Encorafenib Consumption (2017-2022)
-
10.7.2 South Africa Encorafenib Consumption (2017-2022)
-
10.7.3 Egypt Encorafenib Consumption (2017-2022)
-
10.7.4 Algeria Encorafenib Consumption (2017-2022)
-
10.8 Oceania Consumption Analysis
-
10.8.1 Australia Encorafenib Consumption (2017-2022)
-
10.8.2 New Zealand Encorafenib Consumption (2017-2022)
11 Global Encorafenib Competitive Analysis
-
11.1 Array BioPharma
-
11.1.1 Array BioPharma Company Details
-
11.1.2 Array BioPharma Encorafenib Sales, Price, Value and Gross Profit (2017-2022)
-
11.1.3 Array BioPharma Encorafenib Main Business and Markets Served
-
11.1.4 Array BioPharma Encorafenib Product Portfolio
-
11.1.5 Recent Research and Development Strategies
12 Global Encorafenib Market Outlook by Types and Applications to 2028
-
12.1 Global Encorafenib Consumption Forecast and Growth Rate by Type (2022-2028)
-
12.1.1 Global 50mg Capsules Consumption Forecast and Growth Rate (2022-2028)
-
12.1.2 Global 75mg Capsules Consumption Forecast and Growth Rate (2022-2028)
-
12.2 Global Encorafenib Consumption Forecast and Growth Rate by Application (2022-2028)
-
12.2.1 Global Hospital Consumption Forecast and Growth Rate (2022-2028)
-
12.2.2 Global Clinic Consumption Forecast and Growth Rate (2022-2028)
-
12.2.3 Global Pharmacy Consumption Forecast and Growth Rate (2022-2028)
-
12.2.4 Global Other Consumption Forecast and Growth Rate (2022-2028)
13 Country-wise Encorafenib Market Analysis and Outlook to 2028
-
13.1 Global Encorafenib Consumption Forecast (2022-2028)
-
13.2 North America Consumption Analysis
-
13.2.1 United States Encorafenib Consumption Forecast (2022-2028)
-
13.2.2 Canada Encorafenib Consumption Forecast (2022-2028)
-
13.2.3 Mexico Encorafenib Consumption Forecast (2022-2028)
-
13.3 Europe Consumption Analysis
-
13.3.1 Germany Encorafenib Consumption Forecast (2022-2028)
-
13.3.2 UK Encorafenib Consumption Forecast (2022-2028)
-
13.3.3 Spain Encorafenib Consumption Forecast (2022-2028)
-
13.3.4 Belgium Encorafenib Consumption Forecast (2022-2028)
-
13.3.5 France Encorafenib Consumption Forecast (2022-2028)
-
13.3.6 Italy Encorafenib Consumption Forecast (2022-2028)
-
13.3.7 Denmark Encorafenib Consumption Forecast (2022-2028)
-
13.3.8 Finland Encorafenib Consumption Forecast (2022-2028)
-
13.3.9 Norway Encorafenib Consumption Forecast (2022-2028)
-
13.3.10 Sweden Encorafenib Consumption Forecast (2022-2028)
-
13.3.11 Poland Encorafenib Consumption Forecast (2022-2028)
-
13.3.12 Russia Encorafenib Consumption Forecast (2022-2028)
-
13.3.13 Turkey Encorafenib Consumption Forecast (2022-2028)
-
13.4 APAC Consumption Analysis
-
13.4.1 China Encorafenib Consumption Forecast (2022-2028)
-
13.4.2 Japan Encorafenib Consumption Forecast (2022-2028)
-
13.4.3 India Encorafenib Consumption Forecast (2022-2028)
-
13.4.4 South Korea Encorafenib Consumption Forecast (2022-2028)
-
13.4.5 Pakistan Encorafenib Consumption Forecast (2022-2028)
-
13.4.6 Bangladesh Encorafenib Consumption Forecast (2022-2028)
-
13.4.7 Indonesia Encorafenib Consumption Forecast (2022-2028)
-
13.4.8 Thailand Encorafenib Consumption Forecast (2022-2028)
-
13.4.9 Singapore Encorafenib Consumption Forecast (2022-2028)
-
13.4.10 Malaysia Encorafenib Consumption Forecast (2022-2028)
-
13.4.11 Philippines Encorafenib Consumption Forecast (2022-2028)
-
13.4.12 Vietnam Encorafenib Consumption Forecast (2022-2028)
-
13.5 South America Consumption Analysis
-
13.5.1 Brazil Encorafenib Consumption Forecast (2022-2028)
-
13.5.2 Colombia Encorafenib Consumption Forecast (2022-2028)
-
13.5.3 Chile Encorafenib Consumption Forecast (2022-2028)
-
13.5.4 Argentina Encorafenib Consumption Forecast (2022-2028)
-
13.5.5 Venezuela Encorafenib Consumption Forecast (2022-2028)
-
13.5.6 Peru Encorafenib Consumption Forecast (2022-2028)
-
13.5.7 Puerto Rico Encorafenib Consumption Forecast (2022-2028)
-
13.5.8 Ecuador Encorafenib Consumption Forecast (2022-2028)
-
13.6 GCC Consumption Analysis
-
13.6.1 Bahrain Encorafenib Consumption Forecast (2022-2028)
-
13.6.2 Kuwait Encorafenib Consumption Forecast (2022-2028)
-
13.6.3 Oman Encorafenib Consumption Forecast (2022-2028)
-
13.6.4 Qatar Encorafenib Consumption Forecast (2022-2028)
-
13.6.5 Saudi Arabia Encorafenib Consumption Forecast (2022-2028)
-
13.6.6 United Arab Emirates Encorafenib Consumption Forecast (2022-2028)
-
13.7 Africa Consumption Analysis
-
13.7.1 Nigeria Encorafenib Consumption Forecast (2022-2028)
-
13.7.2 South Africa Encorafenib Consumption Forecast (2022-2028)
-
13.7.3 Egypt Encorafenib Consumption Forecast (2022-2028)
-
13.7.4 Algeria Encorafenib Consumption Forecast (2022-2028)
-
13.8 Oceania Consumption Analysis
-
13.8.1 Australia Encorafenib Consumption Forecast (2022-2028)
-
13.8.2 New Zealand Encorafenib Consumption Forecast (2022-2028)
14 Conclusions
The List of Tables and Figures
-
Table Definition of Encorafenib
-
Figure of Encorafenib Picture
-
Table Global Encorafenib Import by Region (Top 10 Countries) (2017-2028)
-
Table Global Encorafenib Export by Region (Top 10 Countries) (2017-2028)
-
Figure Global 50mg Capsules Consumption and Growth Rate (2017-2022)
-
Figure Global 75mg Capsules Consumption and Growth Rate (2017-2022)
-
Figure Global Hospital Consumption and Growth Rate (2017-2022)
-
Figure Global Clinic Consumption and Growth Rate (2017-2022)
-
Figure Global Pharmacy Consumption and Growth Rate (2017-2022)
-
Figure Global Other Consumption and Growth Rate (2017-2022)
-
Figure Global Encorafenib Consumption by Country (2017-2022)
-
Table North America Encorafenib Consumption by Country (2017-2022)
-
Figure United States Encorafenib Consumption and Growth Rate (2017-2022)
-
Figure Canada Encorafenib Consumption and Growth Rate (2017-2022)
-
Figure Mexico Encorafenib Consumption and Growth Rate (2017-2022)
-
Table Europe Encorafenib Consumption by Country (2017-2022)
-
Figure Germany Encorafenib Consumption and Growth Rate (2017-2022)
-
Figure UK Encorafenib Consumption and Growth Rate (2017-2022)
-
Figure Spain Encorafenib Consumption and Growth Rate (2017-2022)
-
Figure Belgium Encorafenib Consumption and Growth Rate (2017-2022)
-
Figure France Encorafenib Consumption and Growth Rate (2017-2022)
-
Figure Italy Encorafenib Consumption and Growth Rate (2017-2022)
-
Figure Denmark Encorafenib Consumption and Growth Rate (2017-2022)
-
Figure Finland Encorafenib Consumption and Growth Rate (2017-2022)
-
Figure Norway Encorafenib Consumption and Growth Rate (2017-2022)
-
Figure Sweden Encorafenib Consumption and Growth Rate (2017-2022)
-
Figure Poland Encorafenib Consumption and Growth Rate (2017-2022)
-
Figure Russia Encorafenib Consumption and Growth Rate (2017-2022)
-
Figure Turkey Encorafenib Consumption and Growth Rate (2017-2022)
-
Table APAC Encorafenib Consumption by Country (2017-2022)
-
Figure China Encorafenib Consumption and Growth Rate (2017-2022)
-
Figure Japan Encorafenib Consumption and Growth Rate (2017-2022)
-
Figure India Encorafenib Consumption and Growth Rate (2017-2022)
-
Figure South Korea Encorafenib Consumption and Growth Rate (2017-2022)
-
Figure Pakistan Encorafenib Consumption and Growth Rate (2017-2022)
-
Figure Bangladesh Encorafenib Consumption and Growth Rate (2017-2022)
-
Figure Indonesia Encorafenib Consumption and Growth Rate (2017-2022)
-
Figure Thailand Encorafenib Consumption and Growth Rate (2017-2022)
-
Figure Singapore Encorafenib Consumption and Growth Rate (2017-2022)
-
Figure Malaysia Encorafenib Consumption and Growth Rate (2017-2022)
-
Figure Philippines Encorafenib Consumption and Growth Rate (2017-2022)
-
Figure Vietnam Encorafenib Consumption and Growth Rate (2017-2022)
-
Table South America Encorafenib Consumption by Country (2017-2022)
-
Figure Brazil Encorafenib Consumption and Growth Rate (2017-2022)
-
Figure Colombia Encorafenib Consumption and Growth Rate (2017-2022)
-
Figure Chile Encorafenib Consumption and Growth Rate (2017-2022)
-
Figure Argentina Encorafenib Consumption and Growth Rate (2017-2022)
-
Figure Venezuela Encorafenib Consumption and Growth Rate (2017-2022)
-
Figure Peru Encorafenib Consumption and Growth Rate (2017-2022)
-
Figure Puerto Rico Encorafenib Consumption and Growth Rate (2017-2022)
-
Figure Ecuador Encorafenib Consumption and Growth Rate (2017-2022)
-
Table GCC Encorafenib Consumption by Country (2017-2022)
-
Figure Bahrain Encorafenib Consumption and Growth Rate (2017-2022)
-
Figure Kuwait Encorafenib Consumption and Growth Rate (2017-2022)
-
Figure Oman Encorafenib Consumption and Growth Rate (2017-2022)
-
Figure Qatar Encorafenib Consumption and Growth Rate (2017-2022)
-
Figure Saudi Arabia Encorafenib Consumption and Growth Rate (2017-2022)
-
Figure United Arab Emirates Encorafenib Consumption and Growth Rate (2017-2022)
-
Table Africa Encorafenib Consumption by Country (2017-2022)
-
Figure Nigeria Encorafenib Consumption and Growth Rate (2017-2022)
-
Figure South Africa Encorafenib Consumption and Growth Rate (2017-2022)
-
Figure Egypt Encorafenib Consumption and Growth Rate (2017-2022)
-
Figure Algeria Encorafenib Consumption and Growth Rate (2017-2022)
-
Table Oceania Encorafenib Consumption by Country (2017-2022)
-
Figure Australia Encorafenib Consumption and Growth Rate (2017-2022)
-
Figure New Zealand Encorafenib Consumption and Growth Rate (2017-2022)
-
Table Array BioPharma Company Details
-
Table Array BioPharma Encorafenib Sales, Price, Value and Gross Profit (2017-2022)
-
Table Array BioPharma Encorafenib Main Business and Markets Served
-
Table Array BioPharma Encorafenib Product Portfolio
-
Figure Global 50mg Capsules Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global 75mg Capsules Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Hospital Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Clinic Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Pharmacy Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Other Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Encorafenib Consumption Forecast by Country (2022-2028)
-
Table North America Encorafenib Consumption Forecast by Country (2022-2028)
-
Figure United States Encorafenib Consumption Forecast and Growth Rate (2022-2028)
-
Figure Canada Encorafenib Consumption Forecast and Growth Rate (2022-2028)
-
Figure Mexico Encorafenib Consumption Forecast and Growth Rate (2022-2028)
-
Table Europe Encorafenib Consumption Forecast by Country (2022-2028)
-
Figure Germany Encorafenib Consumption Forecast and Growth Rate (2022-2028)
-
Figure UK Encorafenib Consumption Forecast and Growth Rate (2022-2028)
-
Figure Spain Encorafenib Consumption Forecast and Growth Rate (2022-2028)
-
Figure Belgium Encorafenib Consumption Forecast and Growth Rate (2022-2028)
-
Figure France Encorafenib Consumption Forecast and Growth Rate (2022-2028)
-
Figure Italy Encorafenib Consumption Forecast and Growth Rate (2022-2028)
-
Figure Denmark Encorafenib Consumption Forecast and Growth Rate (2022-2028)
-
Figure Finland Encorafenib Consumption Forecast and Growth Rate (2022-2028)
-
Figure Norway Encorafenib Consumption Forecast and Growth Rate (2022-2028)
-
Figure Sweden Encorafenib Consumption Forecast and Growth Rate (2022-2028)
-
Figure Poland Encorafenib Consumption Forecast and Growth Rate (2022-2028)
-
Figure Russia Encorafenib Consumption Forecast and Growth Rate (2022-2028)
-
Figure Turkey Encorafenib Consumption Forecast and Growth Rate (2022-2028)
-
Table APAC Encorafenib Consumption Forecast by Country (2022-2028)
-
Figure China Encorafenib Consumption Forecast and Growth Rate (2022-2028)
-
Figure Japan Encorafenib Consumption Forecast and Growth Rate (2022-2028)
-
Figure India Encorafenib Consumption Forecast and Growth Rate (2022-2028)
-
Figure South Korea Encorafenib Consumption Forecast and Growth Rate (2022-2028)
-
Figure Pakistan Encorafenib Consumption Forecast and Growth Rate (2022-2028)
-
Figure Bangladesh Encorafenib Consumption Forecast and Growth Rate (2022-2028)
-
Figure Indonesia Encorafenib Consumption Forecast and Growth Rate (2022-2028)
-
Figure Thailand Encorafenib Consumption Forecast and Growth Rate (2022-2028)
-
Figure Singapore Encorafenib Consumption Forecast and Growth Rate (2022-2028)
-
Figure Malaysia Encorafenib Consumption Forecast and Growth Rate (2022-2028)
-
Figure Philippines Encorafenib Consumption Forecast and Growth Rate (2022-2028)
-
Figure Vietnam Encorafenib Consumption Forecast and Growth Rate (2022-2028)
-
Table South America Encorafenib Consumption Forecast by Country (2022-2028)
-
Figure Brazil Encorafenib Consumption Forecast and Growth Rate (2022-2028)
-
Figure Colombia Encorafenib Consumption Forecast and Growth Rate (2022-2028)
-
Figure Chile Encorafenib Consumption Forecast and Growth Rate (2022-2028)
-
Figure Argentina Encorafenib Consumption Forecast and Growth Rate (2022-2028)
-
Figure Venezuela Encorafenib Consumption Forecast and Growth Rate (2022-2028)
-
Figure Peru Encorafenib Consumption Forecast and Growth Rate (2022-2028)
-
Figure Puerto Rico Encorafenib Consumption Forecast and Growth Rate (2022-2028)
-
Figure Ecuador Encorafenib Consumption Forecast and Growth Rate (2022-2028)
-
Table GCC Encorafenib Consumption Forecast by Country (2022-2028)
-
Figure Bahrain Encorafenib Consumption Forecast and Growth Rate (2022-2028)
-
Figure Kuwait Encorafenib Consumption Forecast and Growth Rate (2022-2028)
-
Figure Oman Encorafenib Consumption Forecast and Growth Rate (2022-2028)
-
Figure Qatar Encorafenib Consumption Forecast and Growth Rate (2022-2028)
-
Figure Saudi Arabia Encorafenib Consumption Forecast and Growth Rate (2022-2028)
-
Figure United Arab Emirates Encorafenib Consumption Forecast and Growth Rate (2022-2028)
-
Table Africa Encorafenib Consumption Forecast by Country (2022-2028)
-
Figure Nigeria Encorafenib Consumption Forecast and Growth Rate (2022-2028)
-
Figure South Africa Encorafenib Consumption Forecast and Growth Rate (2022-2028)
-
Figure Egypt Encorafenib Consumption Forecast and Growth Rate (2022-2028)
-
Figure Algeria Encorafenib Consumption Forecast and Growth Rate (2022-2028)
-
Table Oceania Encorafenib Consumption Forecast by Country (2022-2028)
-
Figure Australia Encorafenib Consumption Forecast and Growth Rate (2022-2028)
-
Figure New Zealand Encorafenib Consumption Forecast and Growth Rate (2022-2028)
-
